Tissue Regenix Group Plc (TRX) - Total Liabilities

Latest as of June 2025: GBX18.56 Million GBX ≈ $2.26K USD

Based on the latest financial reports, Tissue Regenix Group Plc (TRX) has total liabilities worth GBX18.56 Million GBX (≈ $2.26K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Tissue Regenix Group Plc to assess how effectively this company generates cash.

Tissue Regenix Group Plc - Total Liabilities Trend (2007–2024)

This chart illustrates how Tissue Regenix Group Plc's total liabilities have evolved over time, based on quarterly financial data. Check financial resilience of Tissue Regenix Group Plc to evaluate the company's liquid asset resilience ratio.

Tissue Regenix Group Plc Competitors by Total Liabilities

The table below lists competitors of Tissue Regenix Group Plc ranked by their total liabilities.

Company	Country	Total Liabilities
Shapeways Holdings, Inc NASDAQ:SHPWQ	USA	$12.04 Million
Accentro Real Estate AG F:A4Y	Germany	€556.35 Million
Crimson Tide plc LSE:TIDE	UK	GBX1.29 Million
Quantum-Si incorporated NASDAQ:QSIAW	USA	$24.97 Million
H C Slingsby PLC LSE:SLNG	UK	GBX11.04 Million
Hempacco Co., Inc. NASDAQ:HPCO	USA	$18.82 Million
Edgio, Inc. NASDAQ:EGIOQ	USA	$299.67 Million

Liability Composition Analysis (2007–2024)

This chart breaks down Tissue Regenix Group Plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TRX market cap overview.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.63	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.39	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tissue Regenix Group Plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tissue Regenix Group Plc (2007–2024)

The table below shows the annual total liabilities of Tissue Regenix Group Plc from 2007 to 2024.

Year	Total Liabilities	Change
2024-12-31	GBX16.29 Million ≈ $1.98K	+17.30%
2023-12-31	GBX13.89 Million ≈ $1.69K	+6.83%
2022-12-31	GBX13.00 Million ≈ $1.58K	+37.23%
2021-12-31	GBX9.47 Million ≈ $1.15K	+6.63%
2020-12-31	GBX8.88 Million ≈ $1.08K	+50.58%
2019-12-31	GBX5.90 Million ≈ $717.86	+15.85%
2018-12-31	GBX5.09 Million ≈ $619.67	-18.38%
2018-01-31	GBX6.24 Million ≈ $759.23	0.00%
2017-12-31	GBX6.24 Million ≈ $759.23	+202.18%
2016-12-31	GBX2.06 Million ≈ $251.25	-25.95%
2016-01-31	GBX2.79 Million ≈ $339.29	+154.66%
2015-01-31	GBX1.09 Million ≈ $133.23	-39.87%
2014-01-31	GBX1.82 Million ≈ $221.57	+68.31%
2013-01-31	GBX1.08 Million ≈ $131.64	+6.17%
2012-01-31	GBX1.02 Million ≈ $124.00	+154.54%
2011-01-31	GBX400.37K ≈ $48.71	+683.16%
2010-01-31	GBX51.12K ≈ $6.22	-15.55%
2009-01-31	GBX60.53K ≈ $7.37	-27.52%
2008-01-31	GBX83.52K ≈ $10.16	+432.23%
2007-01-31	GBX15.69K ≈ $1.91	--

About Tissue Regenix Group Plc

LSE:TRX UK Biotechnology

Market Cap

$628.37

GBX5.16 Million GBX

Market Cap Rank

#31430 Global

#1311 in UK

Share Price

GBX0.07

Change (1 day)

+0.00%

52-Week Range

GBX0.07 - GBX39.00

All Time High

GBX2162.50